507 results

Digital

Posted on 17.11.2022

Artificial Intelligence pushing the frontiers of healthcare

Working for a company that is at the frontline of digital innovation in medical technologies, I believe that with continued advances in artificial intelligence (AI)-enabled medical devices, the possibility for improving patient lives can reach an entirely new level. AI in healthcare has the potential to solve pressing challenges for European healthcare systems. However, there […]

By Chantal Vets Senior Legal Director, Medtronic

Business

Posted on 08.11.2022

International trade in medical technology leaves the COVID-19 pandemic behind

COVID-19 dampened global trade in medical technology products. So, when we compiled the latest edition of MedTech Europe Facts & Figures (F&F), we knew readers would be keen to see whether the sector had rebounded. (Spoiler alert: it has!) F&F is the ‘go to’ guide to Europe’s medical technology sector. Packed with robust data drawn […]

By Georgiy Bogdanov Officer Market Data

Digital

Posted on 28.10.2022

Advancing health data with a purpose

Digitalisation has great potential to help improve healthcare provision and patient outcomes. This innovative transformation is being addressed both at the practical and policy level. I believe that the success of such transformation is hidden in approaching health data as a means toward a holistic solution, rather than a goal on its own. Over the […]

By Nick Guldemond CEO and Founder

Cardio Digital

Posted on 20.10.2022

The vast possibilities of Artificial Intelligence for our hearts

From triaging patients to the proper treatment to interpreting scans, or optimising treatment pathways, artificial intelligence (AI) can play a pivotal role in supporting the health workforce in their work in cardiovascular disease. However, to fully grasp the potential of AI for patients, we need to start by making high-quality curated health data available. The […]

By Birgit Beger CEO

Business

Posted on 05.10.2022

Thinking of joining an EU project? Read our top tips

The new Innovative Health Initiative (IHI) has prompted companies in the medical technology industry to think about taking part in more EU projects. For some, this is a new opportunity to build on existing experience. For others, it’s a new venture. With the right preparation, there are real benefits on offer thanks to this exciting […]

By Patrick Boisseau Director Research and Innovation, MedTech Europe

Cardio

Posted on 29.09.2022

Early diagnosis can make all the difference to the lives of people with heart failure and other forms of cardiovascular disease

Many public health campaigns focus on the importance of identifying and acting on the symptoms of major cardiovascular disease (CVD) events, such as heart attacks and strokes, as quickly as possible. Medicine has developed so much in recent decades that these events, which were once a death sentence for the majority, are now often survivable […]

By Catherine Hodge Researcher

Digital

Posted on 22.09.2022

How to unlock the value of health data and digital health solutions

At the MedTech Forum that took place in Barcelona earlier this year, I joined a J&J MedTech sponsored panel entitled Data Governance in a Patient Pathway. I was on stage with peers from the industry, all looking at the topic from a different perspective, from the patient, to the healthcare provider, the policy maker to […]

By Lisa Ann Hill Managing Director

Digital Regulation

Posted on 15.09.2022

Should the EU rewrite the rulebook on liability in response to advances in artificial intelligence?

As lawyers we tend to use academic journals to tease out complex legal questions. (See our latest contribution to the literature here). However, today we’re taking the opportunity to discuss a hot topic with a broader audience, as we feel it will have a profound impact on the public, patients and health systems. That topic […]

By Ulrich Juknat Legal Director Regulatory Law

Value

Posted on 14.07.2022

Addressing new expectations for the future of health

The past few years have seen a seismic shift in the entire healthcare landscape. The COVID-19 crisis required a new level of “always-on” and “right now” innovation to enable care to be delivered to the front lines, to all patients, and across geographies. As COVID-19 evolves from an acute crisis to a chronic issue with unpredictable ebbs and flows, the hyper-focused approach to innovation is more important than ever. The world now knows what we can do, even when conditions are less than optimal. Our focus on helping patients by getting the best evidence, tools, and support to clinicians demonstrated the power of collaboration, imagination and dedication. Moving forward, patients and healthcare partners will accept nothing less than that level of commitment to transform the future of health forever.

By Ashley McEvoy Executive Vice President, Worldwide Chair, Johnson & Johnson MedTech